It's a bird! It's a plane! It's

Credit Suisse First Boston

analysts Wendell Laidly and Brent Thill!

After dropping 8% yesterday, many Wall Street eyes were all over


(ORCL) - Get Oracle Corporation Report

, as rumors persisted that the company would be restating its just-released earnings numbers in a 10Q, essentially a quarterly report, sent to the

Securities and Exchange Commission

. Well, today CSFB analysts rushed to the rescue, telling investors that the massive dip was unfounded, because the company will not be restating any financial data. Moving faster than a speeding locomotive, the duo reiterated its strong buy rating.

"To be clear, Oracle has not restated numbers," they wrote in a letter to investors. "This is nothing new here from past 10Qs."


American Express

(AXP) - Get American Express Company Report

produced earnings that were in-line with Wall Street forecasts, but warned about the upcoming 2001 earnings season. Today, it was upgraded to a buy at

Merrill Lynch

and added to the firm's Focus 1 list with a price target of $60.




Usually that kind of news is bad for a stock, but Merrill analyst Michael Hughes said he is bullish on financials as a whole, and would use this weakness as a buying opportunity in the face of future



"We are using the weakness to upgrade American Express," he wrote to investors, "the stock is 18% below the

S&P 500

but we believe provides far superior growth, plus we believe that financials will generally outperform this year with lower interest rates."

Veritas Software

(VRTS) - Get Virtus Investment Partners, Inc. Report

will be releasing earnings this week, and when it does,

Prudential Securities'

analyst David Breiner said the news will be good. Breiner wrote that he expects Veritas to release fourth-quarter earnings that top expectations, with positive future guidance.

"Our key takeaway is that Veritas seems well-positioned to withstand a spending slowdown, given the non-discretionary nature of storage and data availability," he wrote.


Abercrombie & Fitch

(ANF) - Get Abercrombie & Fitch Co. Class A Report

: UP to intermediate-term buy from intermediate-term neutral at Merrill Lynch.



: UP to buy from hold at

UBS Warburg


Duke Energy

(DUK) - Get Duke Energy Corporation (DUK) Report

TheStreet Recommends

: UP to buy from outperform at

Salomon Smith Barney




: UP to intermediate-term accumulate from intermediate-term neutral at Merrill Lynch.

Pacificare Health


: UP to buy from market perform at

Lehman Brothers





: DOWN to hold from buy at CSFB.



: DOWN to hold from buy at CSFB.



: DOWN to market outperform from buy at

Goldman Sachs



(INSP) - Get Inspire Medical Systems, Inc. Report

: DOWN to neutral at

W.R. Hambrecht




: DOWN to neutral at W.R. Hambrecht.



(COST) - Get Costco Wholesale Corporation Report

: NEW market perform at

J.P. Morgan Chase

; price target: $40.

Coventry Health


: NEW buy at Lehman Brothers; price target: $24.

Oxford Health


: NEW strong buy at Lehman Brothers; price target: $45.